Skip to content

Apotheek Baeyaert: what changed

BE 0433.054.520NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€137,572
2024 · €112,447+€25,126
Equity
€1.1m
2024 · €991,268+€137,572
Cash
€975,125
2024 · €723,990+€251,135
Balance sheet total
€1.5m
2024 · €1.2m+€268,176

Largest movements

2024 to 2025
Assets
  • Cash +€251,135

    up €251,135 (+34.7%), from €723,990 to €975,125

    mainly Trade debts (+€141,973) and Net result for the year (+€137,572)

  • Receivables within one year +€37,215

    up €37,215 (+22.6%), from €164,858 to €202,072

    of which Trade receivables: +€85,217

  • Tangible fixed assets -€17,782

    down €17,782 (-16.4%), from €108,188 to €90,406

    of which Plant, machinery and equipment: -€14,547

Equity and liabilities
  • Trade debts +€141,973

    up €141,973 (+119%), from €118,896 to €260,869

  • Profit (loss) carried forward +€137,572

    up €137,572 (+19.8%), from €693,536 to €831,109

Income statement
  • Gross operating margin +€22,420

    up €22,420 (+9.0%), from €249,617 to €272,037

  • Financial income +€9,314

    up €9,314 (+322%), from €2,891 to €12,205

  • Taxes +€4,523

    up €4,523 (+12.1%), from €37,388 to €41,911

  • Staff costs +€3,229

    up €3,229 (+4.5%), from €71,428 to €74,657

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €112,447
Gross operating margin +€22,420
Staff costs -€3,229
Depreciation -€977
Other operating charges -€137
Financial income +€9,314
Financial charges +€2,258
Taxes -€4,523
Result 2025 €137,572
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€254,191
Investment -€3,056
Financing €0
Cash 2024 €723,990
Net result for the year +€137,572
Depreciation +€20,838
Stocks and contracts -€2,719
Receivables within one year -€37,215
Deferred charges and accrued income +€5,110
Trade debts +€141,973
Tax, wage and social debts -€9,538
Other debts +€616
Accrued charges and deferred income -€2,447
Investment in fixed assets (net) -€3,056
Cash 2025 €975,125
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,204,970 €1,473,146 +€268,176 +22.3%
Fixed assets 21/28 €108,188 €90,406 -€17,782 -16.4%
Tangible fixed assets 22/27 €108,188 €90,406 -€17,782 -16.4%
Land and buildings 22 €20,981 €18,984 -€1,997 -9.5%
Plant, machinery and equipment 23 €84,480 €69,933 -€14,547 -17.2%
Furniture and vehicles 24 €2,727 €1,489 -€1,238 -45.4%
Current assets 29/58 €1,096,781 €1,382,739 +€285,958 +26.1%
Stocks and contracts in progress 3 €155,189 €157,908 +€2,719 +1.8%
Stocks 30/36 €155,189 €157,908 +€2,719 +1.8%
Amounts receivable within one year 40/41 €164,858 €202,072 +€37,215 +22.6%
Trade receivables 40 €114,996 €200,213 +€85,217 +74.1%
Other amounts receivable 41 €49,861 €1,859 -€48,002 -96.3%
Current investments 50/53 €31,752 €31,752 = 0.0%
Cash at bank and in hand 54/58 €723,990 €975,125 +€251,135 +34.7%
Deferred charges and accrued income 490/1 €20,991 €15,881 -€5,110 -24.3%
Total equity and liabilities 10/49 €1,204,970 €1,473,146 +€268,176 +22.3%
Equity 10/15 €991,268 €1,128,841 +€137,572 +13.9%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €279,132 €279,132 = 0.0%
Distributable reserves 133 €279,132 €279,132 = 0.0%
Profit (loss) carried forward 14 €693,536 €831,109 +€137,572 +19.8%
Amounts payable 17/49 €213,701 €344,305 +€130,604 +61.1%
Amounts payable within one year 42/48 €207,802 €340,853 +€133,051 +64.0%
Trade debts 44 €118,896 €260,869 +€141,973 +119%
Suppliers 440/4 €118,896 €260,869 +€141,973 +119%
Taxes, remuneration and social security 45 €19,889 €10,352 -€9,538 -48.0%
Taxes 450/3 €8,493 €2,930 -€5,563 -65.5%
Remuneration and social security 454/9 €11,396 €7,422 -€3,974 -34.9%
Other amounts payable 47/48 €69,017 €69,633 +€616 +0.9%
Accrued charges and deferred income 492/3 €5,899 €3,452 -€2,447 -41.5%
Remuneration, social security and pensions 62 €71,428 €74,657 +€3,229 +4.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €19,861 €20,838 +€977 +4.9%
Other operating charges 640/8 €2,776 €2,912 +€137 +4.9%
Gross operating margin 9900 €249,617 €272,037 +€22,420 +9.0%
Operating profit (loss) 9901 €155,552 €173,629 +€18,077 +11.6%
Financial income 75/76B €2,891 €12,205 +€9,314 +322%
Recurring financial income 75 €2,891 €12,205 +€9,314 +322%
Financial charges 65/66B €8,609 €6,350 -€2,258 -26.2%
Recurring financial charges 65 €8,609 €6,350 -€2,258 -26.2%
Profit (loss) for the period before taxes 9903 €149,835 €179,483 +€29,649 +19.8%
Income taxes 67/77 €37,388 €41,911 +€4,523 +12.1%
Profit (loss) for the period 9904 €112,447 €137,572 +€25,126 +22.3%
Profit (loss) for the period to be appropriated 9905 €112,447 €137,572 +€25,126 +22.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€937,431 to €1.1m

Midpoint €999,599 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €1.1m
Capitalised earnings €746,021 to €1.0m
Indication €937,431 to €1.1m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€1,128,841
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.1m

Capitalised earnings

net result for the year (9904)
2025
€137,572
2024
€112,447
2023
€63,311
2022
€131,330
2021
€153,656
Average result
€104,443
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€746,021 / €870,358 / €1.0m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.